Bowel Disease Group Will Use Illumina's BeadChip for IBD Study

The NIDDK Inflammatory Bowel Disease Genetics Consortium will use Illumina's Sentrix HumanHap300 BeadChips and Infinium assay reagents for a genome-wide study, Illumina said last week.

The consortium will genotype over 2,000 case-control samples to help identify genetic variants that increase susceptibility to Crohn's disease.

One thousand control individuals will be typed as part of the study, and the control genotypes will be made available to the scientific community.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.